MARKET

CRMD

CRMD

CORMEDIX
AMEX

Real-time Quotes | Nasdaq Last Sale

6.30
+0.12
+1.94%
After Hours: 6.28 -0.02 -0.32% 17:21 02/14 EST
OPEN
6.28
PREV CLOSE
6.18
HIGH
6.35
LOW
6.20
VOLUME
144.55K
TURNOVER
--
52 WEEK HIGH
10.80
52 WEEK LOW
4.860
MARKET CAP
161.61M
P/E (TTM)
-4.2048
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CRMD and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CRMD News

  • CorMedix on go to sell New Jersey tax credits
  • Seeking Alpha - Article.02/03 21:36
  • CorMedix Approved to Sell $5.5 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program
  • GlobeNewswire.02/03 21:19
  • CorMedix up 11% on accelerated review of Neutrolin in U.S.
  • Seeking Alpha - Article.02/03 15:20
  • CorMedix Inc. Announces FDA Grant Of Rolling Review Of Neutrolin New Drug Application
  • Benzinga.02/03 13:16

More

Industry

Pharmaceuticals
-0.16%
Pharmaceuticals & Medical Research
-0.16%

Hot Stocks

Name
Price
%Change

About CRMD

CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.
More

Webull offers CorMedix Inc. (CRMD) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.